Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations.

Hetherington, Isabella; Totary-Jain, Hana

Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations.

Hetherington, Isabella; Totary-Jain, Hana.

Afiliação

Hetherington I; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC08, 2170, Tampa, FL 33612, USA.
Totary-Jain H; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC08, 2170, Tampa, FL 33612, USA. Electronic address: totaryjainh@usf.edu.

Mol Ther ; 30(10): 3106-3117, 2022 10 05.

Article em En | MEDLINE | ID: mdl-36065464

Assuntos

Aterosclerose; Stents Farmacológicos; Aterosclerose/etiologia; Aterosclerose/terapia; Glucose; Humanos; Lipídeos; RNA Mensageiro; Fatores de Risco; Resultado do Tratamento

Palavras-chave

atherosclerosis; base editing; cardiovascular disease; coronary artery disease; inflammation; mRNA therapeutics; miRNA-switch; nanomedicine; nanotherapy; precision medicine; stroke

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose / Stents Farmacológicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google